TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 28 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29 | -27.5% | 62 | 0.0% | 0.00% | – |
Q2 2023 | $40 | -65.5% | 62 | -55.7% | 0.00% | – |
Q1 2023 | $116 | -56.7% | 140 | -59.1% | 0.00% | – |
Q4 2022 | $268 | – | 342 | +34100.0% | 0.00% | – |
Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2021 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 863,512 | $826,000 | 0.02% |
Level Financial Advisors | 987 | $1,000 | 0.00% |
Westside Investment Management, Inc. | 4 | $0 | 0.00% |
Fortitude Advisory Group L.L.C. | 8 | $0 | 0.00% |
American Portfolios Advisors | 23 | $22 | 0.00% |
Renaissance Technologies | 36,510 | $35,000 | 0.00% |
BARCLAYS PLC | 50,050 | $48,000 | 0.00% |
VANGUARD GROUP INC | 206,428 | $197,000 | 0.00% |
UBS Group AG | 7,123 | $7,000 | 0.00% |
IFP Advisors, Inc | 844 | $3,000 | 0.00% |